Heather B Neuman, MD, MS, FACS

Associate Professor

  • Division of Surgical Oncology

(608) 262-2025

600 Highland Avenue
Box 7375, Clinical Science Center
Madison, WI 53792


  • MD, University of Pittsburg School of Medicine, Pittsburg, PA, 2000
  • Surgical Oncology Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY, 2007-2009
  • Residency in General Surgery, University of North Carolina, Chapel Hill, NC, 2000-2005
  • National Research Service Award Fellow, Agency for Healthcare Research and Quality, Weill Medical College of Cornell University, New York, NY, 2005-2007
  • Research Fellow in Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, 2005-2007
  • MS, Weill Graduate School in Medical Sciences of Cornell University, New York, NY, 2007

Clinical Specialties

Dr. Neuman specializes in surgical oncology with a focus on breast, melanoma and sarcoma. She is certified by the American Board of Surgery.

Research Interests

Dr. Neuman’s research focuses on patient-oriented clinical outcomes including patient decision-making, quality of life and survivorship. Her primary research uses mixed methods to improve the quality and efficiency of breast cancer follow-up provided to breast cancer survivors. Secondary research interests include the use of decision aids to improve patient decision-making surrounding breast cancer surgery. Additionally, she is the principle investigator for a number of surgical clinical trials focused on melanoma.

Recent Publications

    • Pain Control in Breast Surgery: Survey of Current Practice and Recommendations for Optimizing Management-American Society of Breast Surgeons Opioid/Pain Control Workgroup.
    • Rao R, Jackson RS, Rosen B, Brenin D, Cornett W, Fayanju OM, Chen SL, Golesorkhi N, Ludwig K, Ma A, Mautner SK, Sowden M, Wilke L, Wexelman B, Blair S, Gary M, Grobmyer S, Hwang ES, James T, Kapoor NS, Lewis J, Lizarraga I, Miller M, Neuman H, Showalter S, Smith L, Froman J, American Society of Breast Surgeons: Patient Safety & Quality Committee, Research Committee
    • Ann. Surg. Oncol. 2020 Jan 21;
    • [PubMed ID: 31965373]
    • Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01).
    • Stankowski-Drengler TJ, Schumacher JR, Hanlon B, Livingston-Rosanoff D, Van de Walle K, Greenberg CC, Wilke LG, Neuman HB
    • Ann. Surg. Oncol. 2020 Jan 03;
    • [PubMed ID: 31900808]
    • Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women.
    • Vande Walle K, Yang DY, Stankowski-Drengler TJ, Livingston-Rosanoff D, Fernandes-Taylor S, Schumacher JR, Wilke LG, Greenberg CC, Neuman HB
    • Ann. Surg. Oncol. 2019 Dec; 26(13): 4310-4316
    • [PubMed ID: 31538286]
    • Time to initiation of neo-adjuvant chemotherapy for breast cancer treatment does not influence patient survival: A study of US breast cancer patients.
    • Livingston-Rosanoff D, Hanlon B, Marka N, Vande Walle K, Stankowski-Drengler T, Schumacher J, Greenberg CC, Neuman H, Wilke LG
    • Breast J 2019 Sep 12;
    • [PubMed ID: 31513322]
    • A Randomized Controlled Trial Evaluating the Impact of Pre-Consultation Information on Patients' Perception of Information Conveyed and Satisfaction with the Decision-Making Process.
    • Stankowski-Drengler TJ, Tucholka JL, Bruce JG, Steffens NM, Schumacher JR, Greenberg CC, Wilke LG, Hanlon B, Steiman J, Neuman HB
    • Ann. Surg. Oncol. 2019 Oct; 26(10): 3275-3281
    • [PubMed ID: 31342375]

All Publications on PubMed